When examining immune cell infiltration scores in TCGA CRC patients across the four CMS subtypes, we observed that tumors expressing high IL1R1 displayed an increased presence of immune cell populations, such as macrophages and lymphocytes. This evidence concerns the gene IL1R1 and colorectal carcinoma.